Early Clinical outcome of Modified retropubic Versus Transvesical prostatectomy in Management of Benign prostatic hyperplasia: a Randomised Clinical Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN78922760

Enrollment

Registered

2008-07-10

Start date

2007-08-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hyperplasia Urological and Genital Diseases Hyperplasia of prostate

Interventions

1. Modified retropubic prostatectomy 2. Transvesical prostatectomy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients admitted between August 2007 and March 2008 with diagnosis of Benign Prostatic Hyperplasia (BPH) 2. Haemoglobin level of 10 g/dL or more 3. Haematocrit of more than 30%

Exclusion criteria

Exclusion criteria: 1. Suspected prostatic carcinoma 2. Renal failure 3. Cardiac disease 4. Abnormal bleeding tendencies

Design outcomes

Primary

Measure	Time frame
Blood loss determined by haemoglobin and haematocrit levels on the third post operative day	—

Secondary

Measure	Time frame
1. Wound sepsis following surgery 2. Rate of return to operating theatre for clot retention	—

Countries

Uganda

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026